Dr Ahn's passion for Endocrinology and diabetes technology was first kindled after reviewing the first iPhone-compatible glucose meter as an editor for iMedicalApps.com. He is extremely optimistic about the future of digital therapeutics, continuous glucose monitoring, and smart insulin delivery systems. Join this episode to find out more about the impact of technology development and the evolution of CGMs on the diabetic community, especially the Eversense CGM, and the similarities between T1D and T2D.
